Connor, Clark & Lunn Investment Management (CC&L)
TMCI icon

Connor, Clark & Lunn Investment Management (CC&L)’s Treace Medical Concepts TMCI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-45,685
Closed -$307K – 1778
2025
Q3 		$307K Sell
45,685
-53,530
-54% -$350K ﹤0.01% 1358
2025
Q2 		$583K Buy
99,215
+16,726
+20% +$109K ﹤0.01% 1208
2025
Q1 		$692K Buy
82,489
+36,566
+80% +$329K ﹤0.01% 1060
2024
Q4 		$342K Buy
+45,923
New +$307K ﹤0.01% 1234
2024
Q2 		– Sell
-95,008
Closed -$1.24M – 1692
2024
Q1 		$1.24M Sell
95,008
-1,226
-1% -$16.3K 0.01% 819
2023
Q4 		$1.23M Buy
96,234
+5,266
+6% +$53.2K 0.01% 802
2023
Q3 		$1.19M Buy
90,968
+40,048
+79% +$733K 0.01% 770
2023
Q2 		$1.3M Buy
50,920
+18,606
+58% +$480K 0.01% 717
2023
Q1 		$814K Buy
32,314
+8,782
+37% +$206K ﹤0.01% 769
2022
Q4 		$541K Buy
+23,532
New +$542K ﹤0.01% 844

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TMCI Position: Q4 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 45,685 shares — an estimated $307K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TMCI in Q4 2022 and held it in 10 quarters. The position peaked at $1.3M in Q2 2023. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 45,685 Treace Medical Concepts shares in Q4 2025, an estimated $307K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Treace Medical Concepts in Q4 2022 and held it in 10 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Treace Medical Concepts position peaked at $1.3M in Q2 2023.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.